Search - tctmd.com

Displaying 421 - 440 of 555

Sort: Relevancy | Date

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

Presentation TCT 2014

Focal Treatment of Vulnerable Plaque: Stents, Scaffolds, and Prospect ABSORB

Presenter: Valentin Fuster, Patrick W. Serruys, Gregg W. Stone

September 14, 2014

Presentation TCT 2014

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

Presenter: Gregg W. Stone, Pieter C. Smits, Patrick W. Serruys

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Conference News TCT 2014

ABSORB EXTEND: BVS Safe Out to 3 Years

September 14, 2014

Presentation TCT 2014

TCT 615: ABSORB EXTEND: An Interim Report on the 36-Month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Valentin Fuster, Pieter C. Smits

September 13, 2014

Presentation BRS 2014

BRS Capping of Vulnerable Plaque: PROSPECT ABSORB

Presenter: Gregg W. Stone

July 26, 2014

Presentation BRS 2014

Outcomes in Long Lesions and BRS Overlap (with Focus on Sidebranch Closure): ABSORB Extend

Presenter: Alexandre Abizaid

July 26, 2014

Presentation BRS 2014

Is ABSORB ready for an ‘all-comers’ randomized trial? The upcoming COMPARE-ABSORB trial

Presenter: P.C. Smits

July 26, 2014

Presentation BRS 2014

Outcomes of Clinical Registries with ABSORB BVS:Simple Lesions vs_ Real-World

Presenter: Roberto Diletti

July 25, 2014

Presentation BRS 2014

Perspectives on Polymers and Scaffold Design: Evolution ofAbsorb™ BVS

Presenter: Richard J. Rapoza

July 25, 2014

Presentation BRS 2014

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB III + IV Clinical Trial Program

Presenter: Gregg W. Stone

July 25, 2014

Presentation BRS 2014

A Preview to ABSORB II

Presenter: Patrick W. Serruys

July 25, 2014

News Daily News

生物吸收支架表现良好，但是血栓形成引担忧

Todd Neale

July 24, 2014

News Daily News

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Todd Neale

July 24, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Industry News

First Patient Enrolled in PROSPECT II Clinical Trial

June 13, 2014

News Industry News

Cook Medical makes Zilver® PTX® drug-eluting stent available in Canada

June 05, 2014

News Daily News

Personal Radiation Monitor Registers ‘Real Time’ Operator Exposure in Cath Lab

L.A. McKeown

May 30, 2014

Advertisement

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

Focal Treatment of Vulnerable Plaque: Stents, Scaffolds, and Prospect ABSORB

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

ABSORB EXTEND: BVS Safe Out to 3 Years

TCT 615: ABSORB EXTEND: An Interim Report on the 36-Month Clinical Outcomes from the First 250 Patients Enrolled

BRS Capping of Vulnerable Plaque: PROSPECT ABSORB

Outcomes in Long Lesions and BRS Overlap (with Focus on Sidebranch Closure): ABSORB Extend

Is ABSORB ready for an ‘all-comers’ randomized trial? The upcoming COMPARE-ABSORB trial

Outcomes of Clinical Registries with ABSORB BVS:Simple Lesions vs_ Real-World

Perspectives on Polymers and Scaffold Design: Evolution ofAbsorb™ BVS

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB III + IV Clinical Trial Program

A Preview to ABSORB II

生物吸收支架表现良好，但是血栓形成引担忧

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

First Patient Enrolled in PROSPECT II Clinical Trial

Cook Medical makes Zilver® PTX® drug-eluting stent available in Canada

Personal Radiation Monitor Registers ‘Real Time’ Operator Exposure in Cath Lab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content